E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines

por Kurtyka, Courtney A., Chen, Lu, Cress, W. Douglas
Publicado 2014

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma

por Chen, Lu, Kurtyka, Courtney A, Welsh, Eric A, Rivera, Jason I, Engel, Brienne E, Muñoz-Antonia, Teresita, Yoder, Sean J, Eschrich, Steven A, Creelan, Ben C, Chiappori, Alberto A, Gray, Jhanelle E, Ramirez, Jose Luis, Rosell, Rafael, Schabath, Matthew B, Haura, Eric B, Chen, Dung-Tsa, Cress, Douglas W
Publicado 2016